These results might align with previous findings of increased phosphorylated (p)ERK1/2 in ALS samples (Ayala et al., 2011) and would also agree with TDP-43 loss of function in the G93A model, discussed below. Here, MAPK3 is linked to amyotrophic lateral sclerosis.